at follow up 55/75 ( 73 % ) evaluable men and 38/39 ( 97 % ) evaluable women treated with roxithromycin were chlamydia negative compared with 50/71 ( 70 % ) evaluable men and 37/42 ( 88 % ) evaluable women treated with erythromycin .
C0035891
roxithromycin
C0014806
erythromycin